New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPHiA UNITY, a new data-driven consortium designed to accelerate cancer research globally. SOPHiA UNITY aims to bring together leading […]
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences. DARMSTADT, GERMANY Partnership to facilitate collaborative research in academia and industry to further progress in life sciences Multi-dimensional program to build local research capability and startup ecosystem as well as joint R&D projects Further example of Merck’s close cooperation with […]
In collaboration with Microsoft and NVIDIA, SOPHiA GENETICS is developing a comprehensive whole genome analytical solution Boston, US and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that it is collaborating with Microsoft and NVIDIA to leverage their expertise in technology and […]
Espoo, Finland – Euformatics, in partnership with Finland’s BC Platforms and Hungary’s Oncompass Medicine and Genomate Health, has successfully been awarded a contract for the third and final phase of developing clinical reporting of somatic samples for a buyer consortium of seven leading central European hospitals*, represented by the Medical University Graz. This follows on […]
Free, publicly available container solution supported by and built on AWS allows users to create custom on-demand container images to support scientific collaboration and discoveries NEW YORK—Seqera, the leading software provider for complex data analysis in the life sciences space, today announced the launch of Seqera Containers, a no-cost, streamlined bioinformatics container solution, during their […]
NEW YORK, NEW YORK, USA — Basepair Inc., a pioneering provider of bioinformatics solutions, today announced that it is working with Amazon Web Services (AWS) to help accelerate life science organizations’ ability to harness the full potential of genomic data analysis. By integrating AWS HealthOmics capabilities into its cutting-edge Software-as-a-Service (SaaS) platform, Basepair is revolutionizing […]
Cambridge, United Kingdom – Congenica, a UK-based digital health company specialising in innovative software and solutions for genomic data analysis and interpretation, is pleased to announce its selection for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology. The European Union Horizon 2020 co-funded project, ‘INtegrated and STANDardized NGS workflows […]
The Hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDM™ Platform. Located in Belo Horizonte, Brazil, […]
The SOPHiA DDM™ Platform will help broaden the hospital’s cancer testing and diagnostic capabilities Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDM™ Platform. The hospital will use […]
As the first NGS interpretation platform for both oncology and hereditary applications, the updated version of QIAGEN Clinical Insight Interpret is approved for diagnostic use Regulatory framework ensures greater patient protection, transparency of information, and traceability of data Over 4 million NGS patient test cases for oncology and hereditary diseases worldwide processed with QIAGEN Clinical […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
